Selective changes in sensitivity to benzodiazepines, and not other positive GABAA modulators, in rats receiving flunitrazepam chronically

Lisa R Gerak

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Rationale: Tolerance and dependence can develop during chronic benzodiazepine treatment; however, cross tolerance and cross dependence to positive modulators acting at other sites on GABAA receptors might not occur. Objectives: The current study evaluated changes in sensitivity to positive GABAA modulators during chronic treatment with the benzodiazepine flunitrazepam to determine whether cross tolerance and cross dependence varied as a function of site of action. Methods: Eight rats responded under a fixed ratio 20 schedule of food presentation. Dose-effect curves were determined before, during and after chronic treatment with one or two daily injections of 1 mg/kg of flunitrazepam. Results: Prior to chronic treatment, benzodiazepines (flunitrazepam, midazolam), a barbiturate (pentobarbital), a neuroactive steroid (pregnanolone), and drugs with primary mechanisms of action at receptors other than GABAA receptors (morphine, ketamine) dose-dependently decreased responding. Twice daily treatment with flunitrazepam produced 9.5- and 23-fold shifts to the right in the flunitrazepam and midazolam dose-effect curves, respectively. In contrast, dose-effect curves for other drugs either were not changed or were shifted less than or equal to fourfold to the right. Conclusions: Decreased sensitivity to benzodiazepines and not to a barbiturate or a neuroactive steroid during chronic flunitrazepam treatment indicates that tolerance and cross tolerance developed only to benzodiazepines. Despite similar acute behavioral effects among positive GABAA modulators, the differential development of cross tolerance suggests that adaptations at GABAA receptors produced by chronic benzodiazepine treatment differentially affect positive modulators depending on their site of action; such differences might be exploited to benefit patients treated daily with positive GABAA modulators.

Original languageEnglish (US)
Pages (from-to)667-677
Number of pages11
JournalPsychopharmacology
Volume204
Issue number4
DOIs
StatePublished - Jul 2009

Fingerprint

Flunitrazepam
Benzodiazepines
GABA-A Receptors
Midazolam
Therapeutics
Steroids
Pregnanolone
Ketamine
Pentobarbital
Pharmaceutical Preparations
Morphine
Appointments and Schedules
Food
Injections

Keywords

  • Flunitrazepam
  • Pregnanolone
  • Rats
  • Schedule-controlled behavior
  • Tolerance

ASJC Scopus subject areas

  • Pharmacology

Cite this

Selective changes in sensitivity to benzodiazepines, and not other positive GABAA modulators, in rats receiving flunitrazepam chronically. / Gerak, Lisa R.

In: Psychopharmacology, Vol. 204, No. 4, 07.2009, p. 667-677.

Research output: Contribution to journalArticle

@article{8ab722cbce7c4049b59753158736992f,
title = "Selective changes in sensitivity to benzodiazepines, and not other positive GABAA modulators, in rats receiving flunitrazepam chronically",
abstract = "Rationale: Tolerance and dependence can develop during chronic benzodiazepine treatment; however, cross tolerance and cross dependence to positive modulators acting at other sites on GABAA receptors might not occur. Objectives: The current study evaluated changes in sensitivity to positive GABAA modulators during chronic treatment with the benzodiazepine flunitrazepam to determine whether cross tolerance and cross dependence varied as a function of site of action. Methods: Eight rats responded under a fixed ratio 20 schedule of food presentation. Dose-effect curves were determined before, during and after chronic treatment with one or two daily injections of 1 mg/kg of flunitrazepam. Results: Prior to chronic treatment, benzodiazepines (flunitrazepam, midazolam), a barbiturate (pentobarbital), a neuroactive steroid (pregnanolone), and drugs with primary mechanisms of action at receptors other than GABAA receptors (morphine, ketamine) dose-dependently decreased responding. Twice daily treatment with flunitrazepam produced 9.5- and 23-fold shifts to the right in the flunitrazepam and midazolam dose-effect curves, respectively. In contrast, dose-effect curves for other drugs either were not changed or were shifted less than or equal to fourfold to the right. Conclusions: Decreased sensitivity to benzodiazepines and not to a barbiturate or a neuroactive steroid during chronic flunitrazepam treatment indicates that tolerance and cross tolerance developed only to benzodiazepines. Despite similar acute behavioral effects among positive GABAA modulators, the differential development of cross tolerance suggests that adaptations at GABAA receptors produced by chronic benzodiazepine treatment differentially affect positive modulators depending on their site of action; such differences might be exploited to benefit patients treated daily with positive GABAA modulators.",
keywords = "Flunitrazepam, Pregnanolone, Rats, Schedule-controlled behavior, Tolerance",
author = "Gerak, {Lisa R}",
year = "2009",
month = "7",
doi = "10.1007/s00213-009-1497-4",
language = "English (US)",
volume = "204",
pages = "667--677",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Selective changes in sensitivity to benzodiazepines, and not other positive GABAA modulators, in rats receiving flunitrazepam chronically

AU - Gerak, Lisa R

PY - 2009/7

Y1 - 2009/7

N2 - Rationale: Tolerance and dependence can develop during chronic benzodiazepine treatment; however, cross tolerance and cross dependence to positive modulators acting at other sites on GABAA receptors might not occur. Objectives: The current study evaluated changes in sensitivity to positive GABAA modulators during chronic treatment with the benzodiazepine flunitrazepam to determine whether cross tolerance and cross dependence varied as a function of site of action. Methods: Eight rats responded under a fixed ratio 20 schedule of food presentation. Dose-effect curves were determined before, during and after chronic treatment with one or two daily injections of 1 mg/kg of flunitrazepam. Results: Prior to chronic treatment, benzodiazepines (flunitrazepam, midazolam), a barbiturate (pentobarbital), a neuroactive steroid (pregnanolone), and drugs with primary mechanisms of action at receptors other than GABAA receptors (morphine, ketamine) dose-dependently decreased responding. Twice daily treatment with flunitrazepam produced 9.5- and 23-fold shifts to the right in the flunitrazepam and midazolam dose-effect curves, respectively. In contrast, dose-effect curves for other drugs either were not changed or were shifted less than or equal to fourfold to the right. Conclusions: Decreased sensitivity to benzodiazepines and not to a barbiturate or a neuroactive steroid during chronic flunitrazepam treatment indicates that tolerance and cross tolerance developed only to benzodiazepines. Despite similar acute behavioral effects among positive GABAA modulators, the differential development of cross tolerance suggests that adaptations at GABAA receptors produced by chronic benzodiazepine treatment differentially affect positive modulators depending on their site of action; such differences might be exploited to benefit patients treated daily with positive GABAA modulators.

AB - Rationale: Tolerance and dependence can develop during chronic benzodiazepine treatment; however, cross tolerance and cross dependence to positive modulators acting at other sites on GABAA receptors might not occur. Objectives: The current study evaluated changes in sensitivity to positive GABAA modulators during chronic treatment with the benzodiazepine flunitrazepam to determine whether cross tolerance and cross dependence varied as a function of site of action. Methods: Eight rats responded under a fixed ratio 20 schedule of food presentation. Dose-effect curves were determined before, during and after chronic treatment with one or two daily injections of 1 mg/kg of flunitrazepam. Results: Prior to chronic treatment, benzodiazepines (flunitrazepam, midazolam), a barbiturate (pentobarbital), a neuroactive steroid (pregnanolone), and drugs with primary mechanisms of action at receptors other than GABAA receptors (morphine, ketamine) dose-dependently decreased responding. Twice daily treatment with flunitrazepam produced 9.5- and 23-fold shifts to the right in the flunitrazepam and midazolam dose-effect curves, respectively. In contrast, dose-effect curves for other drugs either were not changed or were shifted less than or equal to fourfold to the right. Conclusions: Decreased sensitivity to benzodiazepines and not to a barbiturate or a neuroactive steroid during chronic flunitrazepam treatment indicates that tolerance and cross tolerance developed only to benzodiazepines. Despite similar acute behavioral effects among positive GABAA modulators, the differential development of cross tolerance suggests that adaptations at GABAA receptors produced by chronic benzodiazepine treatment differentially affect positive modulators depending on their site of action; such differences might be exploited to benefit patients treated daily with positive GABAA modulators.

KW - Flunitrazepam

KW - Pregnanolone

KW - Rats

KW - Schedule-controlled behavior

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=67349287876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349287876&partnerID=8YFLogxK

U2 - 10.1007/s00213-009-1497-4

DO - 10.1007/s00213-009-1497-4

M3 - Article

C2 - 19274455

AN - SCOPUS:67349287876

VL - 204

SP - 667

EP - 677

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 4

ER -